Comparison of ovarian cancer markers in endometriosis favours HE4 over CA125

By        

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 5179-5184

Spandidos Publications

Access to resources Recommend Favorite

Clinical Value of CA125, CA19-9, CEA, CA72-4, and TPA in Borderline Ovarian Tumor

By Tamakoshi K.   Kikkawa F.   Shibata K.   Tomoda K.   Obata N.H.   Wakahara F.   Tokuhashi Y.   Ishikawa H.   Kawai M.   Tomoda Y.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 67-72

Academic Press

Access to resources Recommend Favorite

An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions

By Macuks Ronalds  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1811-1817

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian Cancer

By Tuxen M.K.   Soletormos G.   Petersen P.H.   Schioler V.   Dombernowsky P.  

Gynecologic Oncology, Vol. 74, Iss. 1, 1999-07 ,pp. : 12-22

Elsevier

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T.   Marth C.   Kaern J.   Nustad K.   Kristensen G.B.   Trope C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite